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Anti-proliferative activityMushrooms are important sources of natural bioactive compounds. Pleurotus eryngii (DC.) Quél is recog-
nized for its organoleptic quality and health effects, being extensively commercialized. Instead, Suillus
bellinii (Inzenga) Watling is an ectomycorrhizal symbiont, whose main properties were scarcely reported.
Considering current trends, the mycelia and the culture media of these mushrooms might be potential
sources of bioactive compounds. Accordingly, P. eryngii and S. belliniiwere studied for their phenolic acids
and sterols, antioxidant capacity, anti-inflammatory effect and anti-proliferative activity. S. bellinii myce-
lia showed higher contents of ergosterol and phenolic compounds (also higher in its fruiting body) and
stronger antioxidant activity than P. eryngii. Conversely, P. eryngii mycelia showed anti-inflammatory
(absent in S. bellinii mycelia) and a cytotoxicity similar (sometimes superior) to its fruiting bodies, con-
trarily to S. bellinii. Furthermore, the assayed species showed differences in the growth rate and produced
mycelia, which should be considered in further applications.
 2017 Elsevier Ltd. All rights reserved.1. Introduction
Since ancient times, there is a wide interest in using edible
mushrooms as functional foods or sources of natural medicine
components (Shi, Zhao, Jiao, Shi, & Yang, 2013).
Pleurotus eryngii is one of the most favored and widely con-
sumed mushroom species, being also called ‘‘king oyster mush-
room”. Besides its organoleptic quality, P. eryngii is acknowledged
as a good dietary source of bioactive compounds with reported
effects on the reduction of hyperlipidemia (Chen et al., 2012),
tumor growth, hepatogenic and atherosclerotic conditions (Chen
et al., 2014; Yang et al., 2013). Most of the available reports
describe the polysaccharide fraction of P. eryngii, which was high-
lighted as having antioxidant, anti-aging, anti-tumor and hepato-
protective activity (Gan, Ma, Jiang, Wang, & Zeng, 2012;
Jayakumar, Sakthivel, Thomas, & Geraldine, 2008). Nevertheless,
other important bioactive compounds such as polyphenols, pep-
tides, sterols and dietary fiber were also reported in this species(Chen et al., 2012; Ferreira, Barros, & Abreu, 2009; Mishra et al.,
2013).
The genus Suillus includes several C-demanding species, such as
Suillus bellinii (Inzenga) Watling, which are able to produce large
amounts of biomass and exudates (Izumi, Elfstrand, & Fransson,
2013). S. bellinii is an ectomycorrhizal symbiont, which might grow
associated with a wide range of plant hosts (Franco & Castro,
2015). Nevertheless, there are very scarce data on the chemical
composition and bioactivity of this mushroom, having been
reported only for its organic acids, phenolic acids (Ribeiro et al.,
2006), alcohols (Guedes De Pinho et al., 2008) and antimicrobial
activity (Dulger, Hacioglu, & Suerdem, 2006).
Besides the fruiting bodies, the mycelia and the culture media
utilized in mushroom cultivation have also been explored as
potential sources of bioactive compounds (Ma et al., 2016). The
cultured mycelia are becoming a promising alternative as a source
of fungal bioactive compounds, mostly due to the shorter incuba-
tion time and easier culture conditions (less required space, low
probability of contamination and higher production of biomass,
when compared to the fruiting bodies) (Gan et al., 2012; Zhang
et al., 2016).
Considering the species herein, the fruiting bodies of P. eryngii
were previously studied for their chemical composition,
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at different periods (Barreira, Oliveira, & Ferreira, 2014; Lin et al.,
2014; Reis, Barros, Sousa, Martins, & Ferreira, 2014; Reis, Martins,
Barros, & Ferreira, 2012). However, as far as we know, the anti-
inflammatory activity of S. belliniiwas not reported yet. In addition,
the culture media and mycelia of both species were never studied
regarding the anti-tumoral and anti-inflammatory activities.
Accordingly, their composition in phenolic acids and sterols,
antioxidant capacity (scavenging DPPH radicals, reducing power,
b-carotene bleaching inhibition and TBARS formation inhibition),
as well as their anti-proliferative activity (using MCF-7,
NCI-H460, HeLa and HepG2 cell lines) and anti-inflammatory effect
(by down-regulating LPS-stimulated NO in RAW264.7 cells) were
evaluated.
With this study it was mainly intended to evaluate the effects of
different culture conditions on the phenolic acids and ergosterol
profiles and in the bioactivity of both species, to fully characterize
their potential use in food or pharmaceutical applications.2. Materials and methods
2.1. Wild samples and in vitro production of mycelia
Two species of wild mushrooms, Pleurotus eryngii (DC.) Quél
and Suillus belinii (Inzenga) Watling, were collected in Bragança
(Northeast Portugal) during November 2015. Mycelium was iso-
lated from sporocarps of each sample on different solid: i) potato
dextrose agar medium (PDA) (Biolab); ii) Melin-Norkans incom-
plete medium (without micronutrients, casaminoacids and malt
extract) (iMMN solid), and liquid: i) potato dextrose broth (PDB);
ii) Melin-Norkans incomplete (without micronutrients, casaminoa-
cids and malt extract) (iMMN liquid) culture media (Marx, 1969).
Mycelia were grown in Petri dishes with 10 mL of solid media
and flasks with 20 mL of liquid media. Petri dishes and flasks were
placed at 22 C in the dark until mycelium covered most of the
medium: 21 days for P. eryngii and 42 days for S. bellinii, approxi-
mately. Radial growth measurements were registered every week
from the inoculation time until the full growth of the mycelium
(covering all available area). The mycelia were further recovered
from the medium.
Fruiting bodies, mycelia and culture media were lyophilized
(FreeZone 4.5, Labconco, MO, USA) and ground to a fine powder
(20 mesh) and weighted to obtain the dry biomass (dw).2.2. Standards and reagents
Acetonitrile and methanol of high-performance liquid chro-
matography (HPLC) grade were obtained from Lab-Scan (Lisbon,
Portugal). Trolox (6-hydroxy-2,5,7,8- tetramethylchroman-
2-carboxylic acid), ergosterol and phenolic acids standards,
sulforhodamine B, trypan blue, trichloroacetic acid (TCA), tris
lipopolysaccharide (LPS) and dexamethasone were purchased from
Sigma (St. Louis, MO, USA). 2,2-Diphenyl-1-picrylhydrazyl (DPPH)
was obtained from Alfa Aesar (Ward Hill, MA, USA). Dulbecco’s
modified Eagle’s medium (HyClone), Hank’s balanced salt solution
(HBSS) and all the additional culture media components were
purchased from Gibco Invitrogen Life Technologies (Paisley, UK).
RAW264.7 cells were acquired from ECACC (‘‘European Collection
of Animal Cell Culture”) (Salisburg, UK), Griess reagent system kit
was purchased from Promega, thiamine, casamino acids, malt
extract and agar were obtained from Panreac AppliChem
(Barcelona, Spain). The microbial culture media were acquired
from Oxoid microbiology products (Hampshire, United Kingdom).
Other reagents and solvents (analytical grade) were obtained fromcommon sources. Water was treated in a Milli-Q water purification
system (TGI Pure Water Systems, Greenville, SC, USA).
2.3. Preparation of the extracts
The extraction was carried out by stirring the samples (2 g)
with methanol (30 mL) at 25 C and 150 rpm, for 1 h. The extract
was separated from the residue by filtration through Whatman
No. 4 paper to a round flask. The residue was re-extracted once
more under the same conditions and the filtrates were combined
and concentrated under vacuum (rotary evaporator, Büchi, Flawil,
Switzerland) (Reis et al., 2012).
2.4. Chemical characterization of the extracts
2.4.1. Analysis of phenolic acids
The purified extracts were prepared in methanol (20 mg/mL),
filtered through a 0.22 lm nylon syringe filter and further analyzed
by ultra-fast liquid chromatography (UFLC) using a Shimadzu 20A
series (Shimadzu Cooperation, Kyoto, Japan) (Reis et al., 2012). The
quantification (lg/g of extract) was made by comparing the area of
chromatographic peaks (280 and 320 nm) with the calibration
curves (5–100 mg/mL) of the corresponding commercial standards:
protocatechuic acid (y = 164741x, R2 = 0.9996), p-hydroxybenzoic
acid (y = 113523x, R2 = 0.9993), p-coumaric acid (y = 433521x,
R2 = 0.9981) and cinnamic acid (y = 583527x, R2 = 0.9961), 5–
80 lg/mL.
2.4.2. Analysis of ergosterol
The sterol extracts were dissolved in methanol (20 mg/mL), fil-
tered through a 0.22 lm nylon syringe filter and characterized by
high performance liquid chromatography coupled to an ultraviolet
detector (HPLC-UV) (Barreira et al., 2014). Chromatographic data
(obtained at 285 nm) were analyzed using Clarity 2.4 Software
(DataApex, Podohradska, Czech Republic). Ergosterol was quanti-
fied (mg/g of extract) using the internal standard (cholecalciferol)
method.
2.5. Evaluation of bioactive properties
2.5.1. Antioxidant activity
The final extracts were dissolved in methanol at appropriate
concentrations (10–80 mg/mL) and several dilutions were
obtained from the stock solutions: 0.005–50 mg/mL, depending
on the assay.
The sample concentrations providing 50% of antioxidant activ-
ity or 0.5 of absorbance (EC50) were calculated from the graphs
of antioxidant activity percentages (DPPH, b-carotene/linoleate
and TBARS assays) or absorbance at 690 nm (reducing power
assay) against sample concentrations (Heleno, Barros, Sousa,
Martins, & Ferreira, 2010). Trolox was used as standard.
2.5.2. Antioxidant activity
DPPH radical scavenging activity. This methodology was per-
formed using an ELX800 Microplate Reader (Bio-Tek). The reaction
mixture in each one of the 96-wells consisted of one of the differ-
ent concentrations of the extracts (30 mL) and methanolic solution
(270 mL) containing DPPH radicals (6  105 mol/L). The mixture
was left to stand for 60 min in the dark. The reduction of the DPPH
radical was determined by measuring the absorption at 515 nm.
The radical scavenging activity (RSA) was calculated as a
percentage of DPPH discoloration using the equation: % RSA =
[(ADPPH  AS)/ADPPH]  100, where AS is the absorbance of the
solution when the sample extract has been added at a particular
level and ADPPH is the absorbance of the DPPH solution.
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described above. The different concentrations of the extracts
(0.5 mL) were mixed with sodium phosphate buffer (200 mmol/L,
pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v, 0.5 mL). For
each concentration, the mixture was incubated at 50 C for
20 min, and trichloroacetic acid (10% w/v, 0.5 mL) was added.
The mixture (0.8 mL) was poured in the 48-wells, as also deionized
water (0.8 mL) and ferric chloride (0.1% w/v, 0.16 mL), and the
absorbance was measured at 690 nm.
Inhibition of b-carotene bleaching. b-carotene (2 mg) was dis-
solved in chloroform (10 mL) and 2 mL of this solution were pipet-
ted into a round-bottom flask. After the chloroform was removed
at 40 C under vacuum, linoleic acid (40 mg), Tween 80 emulsifier
(400 mg), and distilled water (100 mL) were added to the flask
with vigorous shaking. Aliquots (4.8 mL) of this emulsion were
transferred into different test tubes containing different concentra-
tions of the extracts (0.2 mL). The tubes were shaken and incu-
bated at 50 C in a water bath. As soon as the emulsion was
added to each tube, the zero time absorbance was measured at
470 nm. b-Carotene bleaching inhibition was calculated using the
following equation: (absorbance after 2 h of assay/initial
absorbance)  100.
TBARS (thiobarbituric acid reactive substances) assay. Porcine
brains were obtained from official slaughtered animals, dissected,
and homogenized with a Polytron in ice cold Tris-HCl buffer
(20 mM, pH 7.4) to produce a 1:2 w/v brain tissue homogenate
which was centrifuged at 3000g for 10 min. An aliquot (100 mL)
of the supernatant was incubated with the different concentrations
of the samples solutions (200 mL) in the presence of FeSO4 (10 mM;
100 mL) and ascorbic acid (0.1 mM; 100 mL) at 37 C for 1 h. The
reaction was stopped by the addition of trichloroacetic acid (28%
w/v, 500 mL), followed by thiobarbituric acid (TBA, 2%, w/v,
380 mL), and the mixture was then heated at 80 C for 20 min. After
centrifugation at 3000g for 10 min to remove the precipitated pro-
tein, the color intensity of the malondialdehyde (MDA)-TBA com-
plex in the supernatant was measured by its absorbance at
532 nm. The inhibition ratio (%) was calculated using the following
formula: Inhibition ratio (%) = [(A  B)/A]  100%, where A and B
were the absorbance of the control and the sample solution,
respectively.
2.5.3. Anti-inflammatory activity
Cells treatment. For the anti-inflammatory activity assay, the
methanolic extracts were dissolved in water at a concentrated of
8 mg/mL. For the various assays, the extracts were then submitted
to further dilutions from 0.4 mg/mL to 0.005 mg/mL. The mouse
macrophage-like cell line RAW 264.7 was cultured in DMEM med-
ium supplemented with 10% heat-inactivated foetal bovine serum,
glutamine and antibiotics at 37 C under 5% CO2, in humidified air.
For each experiment, cells were detached with a cell scraper. In the
experiment cell density of 5  105 cells/mL was used, and the pro-
portion of dead cells was less than 5% according to the Trypan blue
dye exclusion test. Cells were seeded in 96-well plates at 150,000
cells/well and allowed do attach to the plate overnight. Subse-
quently, cells were treated with the various concentrations of each
extract for 1 h. Dexamethasone (50 mM) was used as a positive con-
trol for the experiment. The following step was the stimulation
with LPS (1 mg/mL) for 18 h. The effect of all the tested samples
in the absence of LPS was also evaluated, in order to observe if they
induced changes in Nitric oxide (NO) basal levels. In negative con-
trols, no LPS was added. Both extracts and LPS were dissolved in
supplemented DMEM (Souza et al., 2015).
Nitric oxide determination. For the determination of nitric oxide,
a Griess Reagent System kit was used, which contains sulphanil-
amide, N-(1-napthyl)ethylenediamine hydrochloride (NED) and
nitrite solutions. A reference curve of nitrite (sodium nitrite100 mM to 1.6 mM; y = 0.0066x + 0.1349; R2 = 0.9986) was prepared
in a 96-well plate. The cell culture supernatant (100 mL) was trans-
ferred to the plate and mixed with sulphanilamide and NED solu-
tions, 5–10 min each, at room temperature. The nitric oxide
produced was determined by measuring the absorbance at
540 nm (microplate reader ELX800 Biotek), and by comparison
with the standard calibration curve (Souza et al., 2015). The results
were expressed in EC50 values (mg/mL), which correspond to the
sample concentration providing 50% of inhibition of nitric oxide
(NO) production.2.5.4. Cytotoxic activity
The final extracts were dissolved in water at 8 mg/mL and
several dilutions were obtained from the stock solutions:
0.125–0.4 mg/mL. Ellipticine was used as positive control.2.5.4.1. In human tumor cell lines. MCF-7 (breast adenocarcinoma),
NCI-H460 (non-small cell lung carcinoma), HeLa (cervical carci-
noma) and HepG2 (hepatocellular carcinoma) were used as human
tumor cell lines and the cell density determination was performed
using a sulforhodamine B assay previously described by Guimarães
et al. (2013). RPMI-1640 medium containing 10% heat-inactivated
FBS and 2 mM glutamine was used to routinely maintain the
adherent cell cultures at 37 C, in a humidified air incubator con-
taining 5% CO2. For the experiments, each cell line was placed at
an appropriate density (1.0  104 cells/well) into 96-well plates.
A procedure using the sulforhodamine B assay was performed.
The extract concentration that inhibited 50% of the net cell growth
(GI50) was calculated from the graph of sample concentration
against percentage of growth inhibition and expressed in lg/mL
extract.2.5.4.2. In non-tumor cells. The effect of the extracts on the growth
of porcine liver primary cells (PLP2), established by the group, was
evaluated by the sulforhodamine B colorimetric assay with some
modifications as described by Abreu et al. (2011). Briefly, the liver
tissue was rinsed in Hank’s balanced salt solution containing
100 U/mL penicillin + 100 lg/mL streptomycin, and was divided
into 1  1 mm3 explants. Some of them were placed into 25 cm2
tissue flasks containing DMEM medium (supplemented with 10%
fetal bovine serum, 2 mM non-essential amino acids and 100 U/
mL penicillin, 100 mg/mL streptomycin) and incubated at 37 C
under a humidified atmosphere with 5% CO2. Phase contrast micro-
scope was used for direct monitoring of the cell cultivation every
2–3 days. Before reaching the confluence, cells were subcultured
and plated in 96-well plates at a density of 1.0  104 cells/well,
and cultivated in commercial DMEM medium supplemented with
10% FBS, 100 U/mL penicillin and 100 lg/mL streptomycin. The
results were expressed as GI50 values (sample concentration that
inhibited 50% of the net cell growth) in lg/mL extract.2.6. Statistical analysis
Three independent samples of each culture component, fruiting
body and fungal species were used. Data were expressed as
mean ± standard deviation. All statistical tests were performed at
a 5% significance level using IBM SPSS Statistics for Windows, ver-
sion 22.0. (IBM Corp., USA).
The results were compared through one-way ANOVA after
checking the normal distribution of the residuals (Shapiro Wilk’s
test) and the homogeneity of variance (Levene’s test). The depen-
dent variables were classified using multiple comparison tests
(Tukey’s honestly significant difference (HSD) for homoscedastic
distributions and Tamhane’s T2 for the heteroscedastic ones).
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Edible mushrooms, in general, are esteemed primarily for their
nutritional value and bioactive properties mostly provided by dif-
ferent active substances, such as polysaccharides, lipids, peptides,
sterols, or fiber (Ren, Wang, Guo, Yuan, & Yang, 2016). The great
majority of the studies reporting the previous features are con-
ducted on the fruiting body, but the mycelia, as well as the culture
media utilized in different stages of mushroom production, might
also represent a good source of valuable compounds.
Besides the differences in bioactive compounds and corre-
sponding activities, the growth rate and yielded biomass of myce-
lia are of paramount importance, since these parameters might
define the industrial interest of each species. Accordingly, both
indicators are presented in Figs. 1 and 2 to allow a proper assess-
ment of their true applicability. As it can be seen, P. eryngii pre-
sented a higher growth rate, despite the similarities in the
produced biomass (except for the mycelia grown in PDB).
In the following sections, the mycelia and culture media are
compared by evaluating different bioactive compounds and biolog-Fig. 1. Growth in diameter of the mycelia of P. eryngii (A) and S. beical activity indicators. In all tables, results corresponding to wild
samples of each studied species are also presented as reference
values.
3.1. Chemical characterization of the extracts
The phenolic acids profile and ergosterol contents are presented
in Table 1. In general, the fruiting body presented higher contents
in phenolic acids (Fig. 3), but it was very interesting to find that the
mycelium of S. bellinii (independently of the culture conditions)
gave higher contents (8.9–12.4 mg/g extract) in ergosterol (Fig. 3)
than the corresponding wild samples (6.5 mg/g extract). There
are limited data on the sterols content of S. bellinii, but it was
reported as having 12 mg/100 g fw ergosterol (Kalogeropoulos,
Yanni, Koutrotsios, & Aloupi, 2013), which is higher than the values
reported in the present work.
P. eryngii gave lower contents in ergosterol, either considering
the mycelia (0.10–1.0 mg/g extract), as well as the fruiting body
(4.1 mg/g extract), when compared to S. bellinii. The ergosterol con-
tent in P. eryngii was previously reported as 20 mg/100 g dwllinii (B) cultivated in different culture media throughout time.
Table 1
Ergosterol content (mg/g extract) and phenolic acids composition (lg/ g extract) in the mycelia and culture media of P. eryngii and S. bellinii. The values corresponding to the
fruiting body of both mushrooms (wild samples) are also presented. Values are given as mean ± standard deviation.
Ergosterol Protocatechuic acid p-Hydroxybenzoic acid p-Coumaric acid Cinnamic acid
Pleurotus eryngii
Fruiting body (wild) 4.1 ± 0.3 nd 273 ± 10 42 ± 4 61 ± 4
iMMN liquid Mycelium 0.6 ± 0.1b nd 186 ± 8a nd 34 ± 3b
Culture medium nd nd nd nd nd
PDB Mycelium 0.10 ± 0.02c nd 122 ± 6c nd 49 ± 4a
Culture medium nd nd nd nd nd
iMMN solid Mycelium 0.9 ± 0.1a nd 149 ± 9b nd 15 ± 2c
PDA Mycelium 1.0 ± 0.1a nd 178 ± 8a nd 15 ± 2c
p-values (n = 54) Homoscedasticity1 <0.001 – <0.001 – <0.001
1-way ANOVA2 <0.001 – <0.001 – <0.001
Suillus bellinii
Fruiting body (wild) 6.5 ± 0.4 403 ± 16 1821 ± 97 nd 39 ± 4
iMMN Liquid Mycelium 8.9 ± 0.5b nd 213 ± 7c nd 130 ± 1a
Culture medium nd nd nd nd nd
PDB Mycelium 12.4 ± 0.5a nd 204 ± 11c nd 111 ± 4b
Culture medium nd nd nd nd nd
iMMN solid Mycelium 9.0 ± 0.4b nd 394 ± 15a nd 25 ± 2d
PDA Mycelium 3.5 ± 0.3c nd 372 ± 16b nd 36 ± 3c
p-value (n = 54) Homoscedasticity1 <0.001 – <0.001 – <0.001
1-way ANOVA2 <0.001 – <0.001 – <0.001
1 Homoscedasticity among culture components was tested by the Levene test: homoscedasticity, p > 0.05; heteroscedasticity, p < 0.05.
2 p < 0.05 indicates that the mean value of at least one component differs from the others (in this case, multiple comparison tests were performed). For each culture
component, means within a column with different letters differ significantly (p < 0.05).
Fig. 2. Average biomass of P. eryngii and S. bellinii mycelia (mg/Petri dish or Flask).
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mercial samples, which might justify the difference in comparison
to the result reported here.
Among the phenolic acids, p-hydroxybenzoic acid was the
major compound in both mushrooms, reaching quantities nearly
sevenfold higher in S. bellinii (1821 lg/g extract). Nevertheless,
the main phenolic acid in S. bellinii was previously reported as
being p-hydroxyphenylacetic acid (45 lg/100 g fresh weight),
among p-hydroxybenzoic acid derivatives, and o-coumaric acid
(15 lg/100 g fresh weight), in what concerns hydroxycinnamic
acids. In the same study, the concentration of p-hydroxybenzoic
was 7 lg/100 g fresh weight (Kalogeropoulos et al., 2013), which
is in the range of the concentrations detected herein, considering
typical moisture contents (90%) and extraction yields (5%) for
this particular mushroom species.
Concerning P. eryngii, the phenolic acids profile is in agreement
with previous works conducted with samples from the same geo-
graphic area, but different harvesting years (Ferreira et al., 2009;Heleno, Martins, Queiroz, & Ferreira, 2015; Reis et al., 2014). Even
so, in a similar study, syringic acid and vanillic acid were reported
in quantities similar to p-hydroxybenzoic acid (Lin et al., 2014).
3.2. Antioxidant activity
The results obtained for each of the performed antioxidant
activity assays, given as EC50 values, are shown in Table 2. In all
evaluated cases, the highest activity was obtained on the TBARS
formation inhibition assay (P. eryngii: 0.11 mg/mL extract;
S. bellinii: 0.011 mg/mL extract), followed by b-carotene bleaching
inhibition (P. eryngii: 0.45 mg/mL extract; S. bellinii: 0.12 mg/mL
extract), reducing power (P. eryngii: 0.98 mg/mL extract; S. bellinii:
0.16 mg/mL extract) and scavenging effects on DPPH radicals
(P. eryngii: 12.8 mg/mL extract; S. bellinii: 0.61 mg/mL extract). In
line with its higher quantities of phenolic acids, the fruiting bodies
of S. bellinii showed higher antioxidant activity than P. eryngii,
sometimes 10-fold or 20-fold higher, such as verified in the TBARS
Fig. 3. Individual profile of (A) phenolic compounds present in S. bellinii fruiting body recorded at 280 nm (1- protocatechuic acid; 2- p-hydroxybenzoic acid; 3- cinnamic
acid) and (B) ergosterol present in S. bellinii mycelium grown on PDB (1- ergosterol).
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Nevertheless, the values obtained for P. eryngii represent higher
antioxidant activity (except for the DPPH scavenging activity assay)
than that reported previously (Lin et al., 2014; Reis et al., 2012).
Regarding S. bellinii, an activity of 35% in DPPH scavenging
activity, at 0.15 mg/mL was previously reported (Ribeiro et al.,
2006), which is slightly better than the 50% activity obtained in
this study for the 0.61 mg/mL concentration. In a similar study,
performed with Greek samples of S. bellinii, this mushroom also
showed high radical scavenging activity and reducing power, but
the results are not directly comparable, because they were given
in trolox equivalents (Kalogeropoulos et al., 2013).Considering the main purpose of this work, it was very interest-
ing to discover that the antioxidant activity measured in the myce-
lia and in the culture media was very close (in some cases better)
to that verified in the fruiting bodies, emphasizing the high poten-
tial of these fungal culture components. In the case of the culture
media, these results have an increased interest, since those compo-
nents are usually considered as by-products of mushroom cultiva-
tion. Furthermore, the differences among the same culture media,
after having been used to grow each of the mushrooms, indicate
that the measured antioxidant activity is in fact due to the myce-
lium, and not to the culture media components. Furthermore, some
compounds responsible for the antioxidant activity are not
Table 2
Antioxidant activity (EC50 values, mg/mL extract) of the mycelia and culture media of P. eryngii and S. bellinii. The values corresponding to the fruiting body of both mushrooms
(wild samples) are also presented. Values are given as mean ± standard deviation.
DPPH scavenging activity Reducing power b-carotene bleaching inhibition TBARS formation inhibition
Pleurotus eryngii
Fruiting body (wild) 12.8 ± 0.2 0.98 ± 0.01 0.45 ± 0.02 0.11 ± 0.01
iMMN liquid Mycelium 24.9 ± 0.3b 1.35 ± 0.02a 0.44 ± 0.03c 0.17 ± 0.01b
Culture medium 28.2 ± 0.5a 1.24 ± 0.05b 0.57 ± 0.01a 0.20 ± 0.02a
PDB Mycelium 19.7 ± 0.5d 1.10 ± 0.01c 0.40 ± 0.05c 0.15 ± 0.01c
Culture medium 22.0 ± 0.5c 0.95 ± 0.02e 0.52 ± 0.02b 0.17 ± 0.01b
iMMN solid Mycelium 17.1 ± 0.5e 1.08 ± 0.01c 0.23 ± 0.01d 0.13 ± 0.01d
PDA Mycelium 16.1 ± 0.5f 1.03 ± 0.01d 0.18 ± 0.02e 0.11 ± 0.01e
p-value (n = 54) Homoscedasticity1 0.015 <0.001 <0.001 <0.001
1-way ANOVA2 <0.001 <0.001 <0.001 <0.001
Suillus bellinii
Fruiting body (wild) 0.61 ± 0.01 0.16 ± 0.01 0.12 ± 0.01 0.011 ± 0.001
iMMN liquid Mycelium 1.10 ± 0.01b 0.84 ± 0.02b 0.21 ± 0.03b 0.14 ± 0.01a
Culture medium 1.18 ± 0.02a 0.93 ± 0.02a 0.29 ± 0.01a 0.15 ± 0.01a
PDB Mycelium 0.83 ± 0.02d 0.24 ± 0.01d 0.17 ± 0.01d 0.010 ± 0.001c
Culture medium 0.95 ± 0.03c 0.29 ± 0.02c 0.20 ± 0.01c 0.014 ± 0.002bc
iMMN solid Mycelium 0.62 ± 0.03e 0.17 ± 0.01e 0.14 ± 0.02e 0.016 ± 0.001b
PDA Mycelium 0.59 ± 0.02f 0.16 ± 0.01e 0.14 ± 0.01e 0.011 ± 0.001c
p-value (n = 54) Homoscedasticity1 0.003 <0.001 <0.001 <0.001
1-way ANOVA2 <0.001 <0.001 <0.001 <0.001
1 Homoscedasticity among culture components was tested by the Levene test: homoscedasticity, p > 0.05; heteroscedasticity, p < 0.05.
2 p < 0.05 indicates that the mean value of at least one component differs from the others (in this case, multiple comparison tests were performed). For each culture
component, means within a column with different letters differ significantly (p < 0.05).
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Without exception, the mycelia and the culture media of S. bellinii
gave better results than the same components of P. eryngii.
In coherence with the observed for the fruiting bodies, the
results obtained with P. eryngii mycelia were better than the
reported previously, except for DPPH scavenging activity (Reis
et al., 2012).
In general, the detected antioxidant activity represents an
important added-value, despite the weaker performance of the
mycelium and culture medium extracts when compared with the
DPPH scavenging activity (EC50 values ranging from 0.8 to 3 mg/
mL) and reducing power (EC50 = 0.5 mg/mL) obtained in polysac-
charide fractions of P. eryngii (Li & Shah, 2014; Ma et al., 2016;
Zhang et al., 2016). However, it should be reminded that the results
presented herein were obtained with raw extracts, not with puri-
fied fractions.
Due to the lack of studies with the mycelia of S. bellinii, no com-
parisons could be performed.3.3. Anti-inflammatory activity
Macrophages, the main components of the innate immune sys-
tem, have essential regulation functions in several immunopatho-
logical conditions during the inflammatory process (Yoon et al.,
2009; Yuan, Wahlqvist, He, Yang, & Li, 2006). However, the over-
production of inflammatory mediators in the course of uncon-
trolled inflammation processes might cause adverse
consequences in the pathogenesis of many inflammatory diseases
such as cancer, diabetes and cardiovascular disease (Yuan et al.,
2006). Endotoxin lipopolysaccharide (LPS) is able to induce the
production of mediators like nitric oxide (NO), pro-inflammatory
cytokines (besides inhibiting anti-inflammatory cytokines) and
tumor necrosis factor in macrophages. Thereby, macrophages
stimulated by LPS have been widely used for anti-inflammatory
activities evaluation in vitro (García-Lafuente, Guillamón, Villares,
Rostagno, & Martínez, 2009). In addition, due to the reproducible
response of RAW264.7 macrophages to LPS, this cell line has been
widely used for inflammatory research (Huang & Ho, 2010).
Accordingly, the anti-inflammatory activity was evaluated
using a LPS-stimulated RAW264.7 cell line (Table 3). The highestactivity was measured in the methanolic extracts prepared from
the fruiting bodies of S. bellinii (EC50 = 90 lg/mL extract). The
extracts of P. eryngii were also able to suppress NO production,
but in less extent (EC50 = 223 lg/mL extract). However, these
results were better than those obtained in previous assays
(Taofiq et al., 2015).
Regarding the evaluated culture components, some interesting
results were obtained, especially for the mycelia of P. eryngii grown
in solid media, which showed higher anti-inflammatory activity
(EC50 = 184–189 lg/mL extract) than the corresponding fruiting
bodies, highlighting their possible use in anti-inflammatory
applications.
Moro et al. (2012) found that the phenolic compounds of the
fruiting bodies might contribute to their anti-inflammatory activi-
ties, inducing inhibition of NO production and iNOS expression in
LPS-activated RAW264.7 cells. However, the anti-inflammatory
activity of the mycelia of S. bellinii was not maintained in neither
of the culture components, indicating that the anti-inflammatory
effects of the extracts appeared to be related with other compo-
nents besides ergosterol and phenolic acids. Considering the chem-
ical composition of mushroom, this activity might be related with
compounds such as heteropolysaccharides (Lima et al., 2016),
triterpenes (Choi et al., 2014) or carotenoids (Moro et al., 2012).3.4. Cytotoxicity
The results for the anti-proliferative activity assayed in four
human tumor cell lines (MCF-7, NCI-H460, HeLa and HepG2) and
a porcine liver primary cell line (PLP2) are shown in Table 3.
The extracts prepared from the fruiting bodies of wild S. bellinii
samples showed higher activity against MCF7 (GI50 = 70 lg/mL
extract), NCI-H460 (GI50 = 65 lg/mL extract) and HepG2
(GI50 = 68 lg/mL extract). However, the same extracts could not
inhibit the HeLa cell line (up to the maximum assayed concentra-
tion: 400 lg/mL extract). On the other hand, the extracts from the
fruiting bodies of wild P. eryngii samples had a similar behavior in
all cell lines (GI50 values varying from 224 lg/mL extract in HepG2
to 246 lg/mL extract in MCF7). The anti-proliferative activity of P.
eryngii extracts (specifically, its polysaccharides fraction) was pre-
viously reported in HepG2, where it induced apoptosis, cell cycle
Table 3
Anti-proliferative (GI50 values, lg/mL extract) extract and anti-inflammatory activity (EC50 values, lg/mL extract) of the mycelia and culture media of P. eryngii and S. bellinii. The
values corresponding to the fruiting body of both mushrooms (wild samples) are also presented. Values are given as mean ± standard deviation.
MCF-7 NCI-H460 HeLa HepG2 PLP2 RAW264.7
Pleurotus eryngii
Fruiting body (wild) 246 ± 6 237 ± 10 243 ± 10 224 ± 12 >400 223 ± 9
iMMN liquid Mycelium 242 ± 7c 275 ± 12 cd 265 ± 4d 280 ± 3c >400 >400a
Culture medium >400a >400a >400a >400a >400 >400a
PDB Mycelium 270 ± 15b 268 ± 5d 280 ± 1c 224 ± 11d >400 308 ± 10b
Culture medium >400a >400a >400a >400a >400 >400a
iMMN solid Mycelium 169 ± 12d 363 ± 13b 302 ± 9b 314 ± 2b >400 189 ± 7c
PDA Mycelium 173 ± 8d 285 ± 10c 267 ± 20d 140 ± 6e >400 184 ± 6c
p-value (n = 54) Homoscedasticity <0.001 <0.001 <0.001 <0.001 – <0.001
1-way ANOVA <0.001 <0.001 <0.001 <0.001 – <0.001
Suillus bellinii
Fruiting body (wild) 70 ± 2 65 ± 3 >400 68 ± 3 215 ± 38 90 ± 2
iMMN liquid Mycelium >400a >400a >400 >400a >400 >400
Culture medium >400a >400a >400 >400a >400 >400
PDB Mycelium 300 ± 7b 279 ± 2b >400 226 ± 5b >400 >400
Culture medium >400a >400a >400 >400a >400 >400
iMMN solid Mycelium >400a >400a >400 >400a >400 >400
PDA Mycelium 289 ± 11c 257 ± 2c >400 206 ± 11c >400 >400
p-value (n = 54) Homoscedasticity <0.001 <0.001 – <0.001 – –
1-way ANOVA <0.001 <0.001 – <0.001 – –
1Homoscedasticity among culture components was tested by the Levene test: homoscedasticity, p > 0.05; heteroscedasticity, p < 0.05.
2p < 0.05 indicates that the mean value of at least one component differs from the others (in this case, multiple comparison tests were performed). For each culture
component, means within a column with different letters differ significantly (p < 0.05).
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gen species (Yang et al., 2013). Besides its in vitro anti-tumoral
activity, P. eryngii was previously reported as being active against
mice renal cancer in vivo (Yang et al., 2013). Despite their generally
lower activity against tumor cell lines, the extracts from P. eryngii
did not exhibit a toxic effect on the primary cell line, contrarily
with the observed for S. bellinii fruiting bodies.
Interestingly, none of the assayed culture components inhibit
the growth of PLP2 cell line, which constitutes a good indicator
of the lack of toxicity of the mycelia and culture media of both
mushroom species in non-tumor cell lines.
Concerning the tumor cell lines, the mycelia of P. eryngii showed
similar cytotoxicity to the fruiting bodies. In fact, the measured
activity was often higher than the observed for the fruiting bodies.
In some cases, such as the mycelium grown in PDA medium, the
GI50 values are comparable to those obtained with purified
polysaccharide fractions (Ma et al., 2014, 2016; Ren et al., 2016),
which represents a very interesting result.
On the other hand, the mycelia of S. bellinii showed significantly
lower anti-proliferative activity, when compared to the fruiting
bodies.
The culture media did not show any anti-proliferative activity
(up to the maximum assayed concentrations) in both mushroom
species
4. Conclusion
This study was initially designed to evaluate the mycelia of P.
eryngii and S. bellinii, as well as their culture media, as potential
alternative sources of bioactive compounds or as ingredients to
be used in applications with antioxidant, anti-inflammatory or
cytotoxic activities. In general, S. bellinii mycelia showed higher
contents of ergosterol and phenolic compounds, which were also
more abundant in the fruiting body of this species. Likewise, the
antioxidant activity was also higher among the S. bellinii compo-
nents. However, these extracts did not show anti-inflammatory
activity up to the maximum assayed concentrations, contrarily to
the observed for the mycelia of P. eryngii. Furthermore, the latter
component showed a cytotoxicity similar (and often superior) to
its fruiting bodies, in opposition to S. bellinii, whose myceliashowed a significant loss of anti-proliferative activity. In general,
each culture component showed differentiated activity, which
should be considered together with the growth rate and biomass
yielded for each mushroom.
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